期刊文献+

多发性硬化患者脑脊液组胺水平与EDSS评分的相关性分析 被引量:4

Correlation analysis of the level of cerebrospinal fluid histamine and EDSS score in patients with multiple sclerosis
下载PDF
导出
摘要 目的分析多发性硬化(MS)患者脑脊液组胺水平与临床神经功能障碍程度的相关性。方法 2014年10月-2015年6月昆明医科大学第一附属医院神经内科和解放军昆明总医院神经内科收治MS患者46例(观察组),其中复发缓解型MS(RRMS亚组)患者29例,继发进展型MS(SPMS亚组)患者17例。另选择健康志愿者40例为健康对照组,采用酶联免疫吸附试验(ELISA)对2组脑脊液组胺水平进行检测及比较,并分析组胺水平与临床扩展致残量表评分(EDSS评分)的相关性。结果观察组患者脑脊液组胺水平明显高于健康对照组[(36.4±8.7)pg/ml vs.(8.9±3.7)pg/ml,t=2.86,P<0.01]。EDSS评分高于健康对照组[(3.8±1.1)分vs.(0.3±0.1)分,t=3.74,P<0.01]。RRMS亚组组胺水平低于SPMS亚组患者[(32.2±8.6)pg/ml vs.(40.6±5.1)pg/ml,t=2.09,P<0.05];EDSS评分显著低于SPMS亚组[(2.5±1.2)分vs.(4.9±1.4)分,t=2.82,P<0.01]。MS患者脑脊液组胺水平与EDSS评分呈正相关(r=0.66,P<0.01)。结论脑脊液组胺可以作为评价MS致残程度的实验室指标,且组胺及其受体可能成为治疗MS药物的潜在靶点。 Objective To analyze the correlation between the level of cerebrospinal fluid(CSF) histamine and the degree of clinical neurological dysfunction in patients with multiple sclerosis(MS).Methods From October 2014 to June2015,46 MS patients who were admitted to Department of neurology,Kunming Medical University First Affiliated Hospital were enrolled as observation group,including the relapsing remitting MS(RRMS) subgroup of patients(29 cases) and secondary progressive MS(SPMS sub group) of 17 patients.40 cases of healthy volunteers were enrolled as healthy control group,by enzyme linked immunosorbent assay(ELISA),CSF histamine levels of the two groups were detected and compared and analysis histamine levels and clinical extended disability scale score(EDSS) correlation.Results The histamine levels in the observation group were significantly higher than those in the healthy control group[(36.4 ±8.7) pg/ml vs.(8.9 ±3.7)pg/ml,t = 2.86,P〈0.01].EDSS score was higher than that of healthy control group[(3.8 ± 1.1) points vs.(0.3 ±0.1)points,t =3.74,P〈0.01].RRMS subgroup histamine levels below the SPMS subgroups of patients[(32.2 ±8.6) pg/ ml vs.(40.6 ±5.1) pg/ ml,t =2.09,P〈0.05];EDSS score was significantly lower than that of SPMS subgroup[(2.5 ±1.2) points vs.(4.9 ± 1.4) points,t = 2.82,P〈0.01].The levels of histamine in MS patients were positively correlated with EDSS score(r =0.66,P〈0.01).Conclusion Cerebrospinal fluid histamine can be used as a laboratory index for evaluating the degree of disability in MS,and histamine and its receptors may be potential targets for the treatment of MS.
出处 《疑难病杂志》 CAS 2016年第5期441-444,共4页 Chinese Journal of Difficult and Complicated Cases
基金 云南省自然科学基金应用基础研究项目(2013FB146)
关键词 多发性硬化 组胺 脑脊液 临床扩展致残量表评分 Multiple sclerosis Histamine Cerebrospinal fluid Clinical extended disability scale score
  • 相关文献

参考文献18

  • 1吕慧娟,朱路文,唐强.炎症反应在多发性硬化中作用机制研究进展[J].中国医学创新,2015,12(12):129-131. 被引量:5
  • 2JADIDI-NIARAGH F, MIRSHAFIEY A. Histamine and histamine re- ceptors in pathogenesis and treatmerlt of multiple sclerosis [ J ]. Neu- ropharmacology,2010,59 ( 3 ) : 180-189.
  • 3POLMAN C H, REINGOLD S C, BANWELL B, et al. Diagnostic cri- teria for multiple sclerosis: 2010 revisions to the McDonald criteria [ J ]. Ann Neurol,2011,69 ( 2 ) :292-302.
  • 4KURTZKE J F. Rating neurologlc impairment in multiple-sclerosis-an expanded disability status scale ( EDSS ) [ J ]. Neurology, 1983,33 (11) :1444-1452.
  • 5张皓,刘诗翔,孔繁一,胡炜娜,贺艳琴.应用EDSS系统评价高压氧治疗多发性硬化患者的临床疗效[J].西部医学,2014,26(1):74-76. 被引量:3
  • 6MARTINS T B, ROSE J W, JASKOWSKI T D, et al. Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoas- say[ J]. Am J Clin Pathol,2011,136 (5) :696-704.
  • 7孙博,李呼伦.在多发性硬化的免疫病理过程中不同免疫细胞的作用[J].中国免疫学杂志,2015,31(12):1585-1590. 被引量:19
  • 8SALIGRAMA N,CASE L K,DEL RIO R,et al. Systemic lack of ca- nonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis [ J ]. J Immunol, 2013,191 ( 2 ) : 614- 622.
  • 9KALLWEIT U, ARITAKE K, BASSETH C L, et al. Elevated CSF histamine levels in multiple sclerosis patients [ J ]. Fluids Barriers CNS,2013,10(10) :19.
  • 10TUOMISTO L, KILPELMNEN H, RIEKKINEN P. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis[ J]. Agents Actions, 1983, 13 (2-3) : 255-257.

二级参考文献97

  • 1张为,曾丽.CD4^+T细胞及其亚群与多发性硬化[J].中国临床康复,2006,10(4):156-158. 被引量:11
  • 2De Stefano N, Giorgio A, Battaglini M, et al. Assessing brain atrophyrates in a large population of untreated multiple sclerosis subtypes [ J ]. Neurology ,2010,74 (23) : 1868-1~76.
  • 3Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis [ J ]. Ann Neurol, 2010,68(4) :477-493.
  • 4Ndrodias G, Reynolds R, Chanal M, et al. Meningeal T ceils associate- with diffuse axonal loss in multiple sclerosis spinal cords [ J ]. Ann Neu- rol,2010,68 (4) :465-476.
  • 5Gilmore CP, Donaldson I, Bo L, et al. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a com- parison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord[ J ]. . Neurol Neurosurg Psychiatry ,2009,80 (2) :182-187.
  • 6Tutuneu M,Tang J,Zeid NA, et al. Onset of progressive phase is an age- dependent clinical milestone in multiple sclerosis [ J ]. Mult Scler ,2013, 19(2) :188-198.
  • 7Ramagopalan SV, Dobson R, Meier UC, et al. Multiple sclerosis: risk factors, prodromes, and potential causal pathways[ J ]. Lancet Neurol, 2010,9(7) :727-739.
  • 8Lovato L, Willis SN, Rodig SJ, et al. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis [ J ]. Brain, 2011 , 134 ( Pt 2) : 534-541.
  • 9Evans J. Epidemiology in practice:randomised controlled trials[J].Community Eye Health,1998,(26):26-27.
  • 10John F. Kurtzke Rating Neurologic impairment in Multiple Sclerosis an expanded disability status scale (EDSS)[J].{H}NEUROLOGY,1983.1444-1453.

共引文献27

同被引文献34

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部